Citation Information :
Aggarwal A, Arora U, Mittal A, Aggarwal A, Singh K, Jorwal P, Nischal N, Singh AK. Outcomes of HFNC Use in COVID-19 Patients in Non-ICU Settings: A Single-center Experience. Indian J Crit Care Med 2022; 26 (4):530-532.
Ray A, Jain D, Goel A, Agarwal S, Swaroop S, Das P, et al. Clinico-pathological features in fatal COVID-19 infection: a preliminary experience of a tertiary care center in North India using postmortem minimally invasive tissue sampling. Expert Rev Respir Med 2021;15(10):1367–1375. DOI: 10.1080/17476348.2021.1951708.
Raoof S, Nava S, Carpati C, Hill NS. High-flow, noninvasive ventilation and awake (nonintubation) proning in patients with coronavirus disease 2019 with respiratory failure. Chest 2020;158(5):1992–2002. DOI: 10.1016/j.chest.2020.07.013.
Kodama T, Obinata H, Mori H, Murakami W, Suyama Y, Sasaki H, et al. Prediction of an increase in oxygen requirement of SARS-CoV-2 pneumonia using three different scoring systems. J Infect Chemother 2021;27(2):336–341. DOI: 10.1016/j.jiac.2020.12.009.
Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M, et al. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: a multi-centre prospective observational study. EClinicalMedicine 2020;28. Available from: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30314-X/abstract.
Lu X, Jiang L, Chen T, Wang Y, Zhang B, Hong Y, et al. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19. Respir Res 2020;21(1):194. DOI: 10.1186/s12931-020-01455-4.
